Pacer Advisors Inc. Buys New Shares in American Healthcare REIT, Inc. $AHR

Pacer Advisors Inc. purchased a new stake in American Healthcare REIT, Inc. (NYSE:AHR) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 29,205 shares of the company’s stock, valued at approximately $1,377,000.

Several other institutional investors also recently modified their holdings of AHR. Manning & Napier Advisors LLC bought a new position in American Healthcare REIT in the first quarter worth $26,000. Garton & Associates Financial Advisors LLC bought a new position in American Healthcare REIT during the 4th quarter valued at about $26,000. Kemnay Advisory Services Inc. acquired a new position in shares of American Healthcare REIT in the 4th quarter worth approximately $29,000. Darwin Wealth Management LLC bought a new stake in shares of American Healthcare REIT during the second quarter worth $31,000. Finally, Los Angeles Capital Management LLC acquired a new stake in American Healthcare REIT in the 4th quarter valued at about $34,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

American Healthcare REIT Trading Up 3.8%

NYSE AHR opened at $56.80 on Friday. American Healthcare REIT, Inc. has a one year low of $39.64 and a one year high of $58.70. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.45 and a quick ratio of 0.45. The firm has a market cap of $10.95 billion, a P/E ratio of 83.54, a P/E/G ratio of 1.90 and a beta of 0.76. The stock’s 50-day moving average is $52.18 and its 200-day moving average is $50.70.

American Healthcare REIT (NYSE:AHR) last posted its earnings results on Thursday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. American Healthcare REIT had a return on equity of 3.78% and a net margin of 4.84%.The business had revenue of $674.25 million during the quarter, compared to analysts’ expectations of $645.30 million. During the same period in the prior year, the business earned $0.42 EPS. American Healthcare REIT’s revenue for the quarter was up 24.3% compared to the same quarter last year. American Healthcare REIT has set its FY 2026 guidance at 2.150-2.190 EPS. Sell-side analysts anticipate that American Healthcare REIT, Inc. will post 2.17 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Tuesday, June 30th. American Healthcare REIT’s dividend payout ratio is 147.06%.

Insider Transactions at American Healthcare REIT

In related news, CFO Brian Peay sold 25,000 shares of the stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $50.70, for a total transaction of $1,267,500.00. Following the completion of the transaction, the chief financial officer directly owned 152,700 shares in the company, valued at approximately $7,741,890. This trade represents a 14.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Mark E. Foster sold 2,500 shares of American Healthcare REIT stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $48.58, for a total value of $121,450.00. Following the completion of the sale, the executive vice president directly owned 52,995 shares in the company, valued at approximately $2,574,497.10. This represents a 4.50% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 29,500 shares of company stock valued at $1,485,590. Corporate insiders own 0.75% of the company’s stock.

Wall Street Analysts Forecast Growth

AHR has been the topic of a number of recent research reports. UBS Group increased their price objective on American Healthcare REIT from $60.00 to $63.00 and gave the company a “buy” rating in a research report on Wednesday, July 8th. Citizens Jmp raised their price target on American Healthcare REIT from $60.00 to $65.00 and gave the company a “market outperform” rating in a report on Monday, July 27th. Barclays started coverage on American Healthcare REIT in a research report on Tuesday, July 7th. They issued an “overweight” rating and a $61.00 price objective for the company. Citigroup restated an “outperform” rating on shares of American Healthcare REIT in a research report on Monday, July 27th. Finally, Compass Point started coverage on shares of American Healthcare REIT in a research report on Tuesday, July 21st. They set a “buy” rating and a $70.00 price target for the company. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $58.83.

American Healthcare REIT News Summary

Here are the key news stories impacting American Healthcare REIT this week:

• Positive Sentiment: Quarterly results exceeded expectations: AHR reported second-quarter EPS of $0.16, above the $0.14 analyst consensus, while revenue reached $674.25 million versus expectations of $645.30 million. Revenue increased 24.3% year over year, supporting investor confidence in the company’s operating momentum. American Healthcare REIT quarterly earnings report
• Positive Sentiment: 2026 guidance was raised: Management now expects full-year EPS of $2.15 to $2.19, above the roughly $2.07 consensus estimate. The improved forecast was attributed to stronger performance and suggests earnings visibility has improved. American Healthcare REIT raises outlook
• Positive Sentiment: FFO and sector fundamentals remain supportive: Reports highlighted higher normalized funds from operations, strong same-store net operating income growth, senior-housing demographic tailwinds and an acquisition pipeline focused on distressed SHOP assets. These factors could support future cash flow and portfolio growth. American Healthcare REIT raises 2026 forecasts
• Neutral Sentiment: An investment analysis described AHR’s balance-sheet discipline and growth prospects favorably but maintained a Hold rating, indicating that the positive operating outlook may already be reflected in the valuation. American Healthcare REIT investment analysis
• Negative Sentiment: Risks include strong competition, aging properties and what analysts characterized as a relatively passive acquisition strategy. Additionally, reported EPS declined from $0.42 in the prior-year quarter to $0.16, despite beating the latest estimate.

American Healthcare REIT Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare?related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long?term net lease or triple?net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high?growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.